GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma

Penny E. Lovat, Serafina Oliverio, Marco Ranalli, Marco Corazzari, Carlo Rodolfo, Francesca Bernassola, Karen Aughton, Mauro Maccarrone, Quentin D Campbell Hewson, Andy D J Pearson, Gerry Melino, Mauro Piacentini, Christopher P F Redfern

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

The synthetic retinoid fenretinide induces apoptosis of neuroblastoma cells and in vitro acts synergistically with chemotherapeutic drugs used to treat neuroblastoma. The mechanisms of fenretinide-induced cell death of neuroblastoma cells are complex, involving cellular signaling pathways as yet incompletely defined but, in part, involving the generation of reactive oxygen species (ROS). In an attempt to characterize the mechanism of action of fenretinide, cDNA array filters were screened to identify apoptotic genes regulated in response to treatment of SH-SY5Y cells with fenretinide. Expression of the stress-induced transcription factor, GADD153, was up-regulated at both the protein and mRNA levels in response to fenretinide. Overexpression of GADD153 increased apoptosis in the presence and absence of fenretinide, whereas reduced expression of GADD153 by expression of antisense DNA abrogated the response to fenretinide. Although fenretinide is a partial retinoic acid receptor (RAR)-β/γ agonist, RARβ/γ antagonists did not block the induction of GADD153 by fenretinide; conversely, the induction of GADD153 was blocked by antioxidants. Enzyme inhibitors were used to identify pathways mediating the ROS-dependent effects of fenretinide: inhibitors of phospholipase A2 and lypoxygenases (LOX), and specific inhibitors of 12-LOX, but not 5-LOX or 15-LOX, inhibited the induction of ROS, apoptosis, and GADD153 in response to fenretinide. The inhibition of ROS and apoptosis was reversed by the addition of the 12-LOX products, 12 (S)-hydroperoxyeicosatetraenoic acid (12-HpETE) and 12 (S)-hydroxyeicosatetraenoic acid (12-HETE). Fenretinide did not increase free arachidonic acid levels, but increased LOX activity without a detectable increase in 12-LOX protein. These results suggest that fenretinide induces apoptosis via RAR-dependent and -independent pathways in which the RAR-independent pathway is characterized by a fenretinide-dependent increase in 12-LOX activity, leading to the induction of GADD153. The targeting of 12-LOX and/or GADD153 in neuroblastoma cells may thus present a novel pathway for the development of drugs inducing apoptosis of neuroblastoma with improved tumor specificity.

Original languageEnglish
Pages (from-to)5158-5167
Number of pages10
JournalCancer Research
Volume62
Issue number18
Publication statusPublished - Sep 15 2002

Fingerprint

Fenretinide
Arachidonate 12-Lipoxygenase
Neuroblastoma
Apoptosis
Retinoic Acid Receptors
Reactive Oxygen Species
Antisense DNA
Phospholipase A2 Inhibitors
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
Retinoids
Enzyme Inhibitors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lovat, P. E., Oliverio, S., Ranalli, M., Corazzari, M., Rodolfo, C., Bernassola, F., ... Redfern, C. P. F. (2002). GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. Cancer Research, 62(18), 5158-5167.

GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. / Lovat, Penny E.; Oliverio, Serafina; Ranalli, Marco; Corazzari, Marco; Rodolfo, Carlo; Bernassola, Francesca; Aughton, Karen; Maccarrone, Mauro; Hewson, Quentin D Campbell; Pearson, Andy D J; Melino, Gerry; Piacentini, Mauro; Redfern, Christopher P F.

In: Cancer Research, Vol. 62, No. 18, 15.09.2002, p. 5158-5167.

Research output: Contribution to journalArticle

Lovat, PE, Oliverio, S, Ranalli, M, Corazzari, M, Rodolfo, C, Bernassola, F, Aughton, K, Maccarrone, M, Hewson, QDC, Pearson, ADJ, Melino, G, Piacentini, M & Redfern, CPF 2002, 'GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma', Cancer Research, vol. 62, no. 18, pp. 5158-5167.
Lovat PE, Oliverio S, Ranalli M, Corazzari M, Rodolfo C, Bernassola F et al. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. Cancer Research. 2002 Sep 15;62(18):5158-5167.
Lovat, Penny E. ; Oliverio, Serafina ; Ranalli, Marco ; Corazzari, Marco ; Rodolfo, Carlo ; Bernassola, Francesca ; Aughton, Karen ; Maccarrone, Mauro ; Hewson, Quentin D Campbell ; Pearson, Andy D J ; Melino, Gerry ; Piacentini, Mauro ; Redfern, Christopher P F. / GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. In: Cancer Research. 2002 ; Vol. 62, No. 18. pp. 5158-5167.
@article{bc3c7a0204224b0aa9ab7a8966cc9803,
title = "GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma",
abstract = "The synthetic retinoid fenretinide induces apoptosis of neuroblastoma cells and in vitro acts synergistically with chemotherapeutic drugs used to treat neuroblastoma. The mechanisms of fenretinide-induced cell death of neuroblastoma cells are complex, involving cellular signaling pathways as yet incompletely defined but, in part, involving the generation of reactive oxygen species (ROS). In an attempt to characterize the mechanism of action of fenretinide, cDNA array filters were screened to identify apoptotic genes regulated in response to treatment of SH-SY5Y cells with fenretinide. Expression of the stress-induced transcription factor, GADD153, was up-regulated at both the protein and mRNA levels in response to fenretinide. Overexpression of GADD153 increased apoptosis in the presence and absence of fenretinide, whereas reduced expression of GADD153 by expression of antisense DNA abrogated the response to fenretinide. Although fenretinide is a partial retinoic acid receptor (RAR)-β/γ agonist, RARβ/γ antagonists did not block the induction of GADD153 by fenretinide; conversely, the induction of GADD153 was blocked by antioxidants. Enzyme inhibitors were used to identify pathways mediating the ROS-dependent effects of fenretinide: inhibitors of phospholipase A2 and lypoxygenases (LOX), and specific inhibitors of 12-LOX, but not 5-LOX or 15-LOX, inhibited the induction of ROS, apoptosis, and GADD153 in response to fenretinide. The inhibition of ROS and apoptosis was reversed by the addition of the 12-LOX products, 12 (S)-hydroperoxyeicosatetraenoic acid (12-HpETE) and 12 (S)-hydroxyeicosatetraenoic acid (12-HETE). Fenretinide did not increase free arachidonic acid levels, but increased LOX activity without a detectable increase in 12-LOX protein. These results suggest that fenretinide induces apoptosis via RAR-dependent and -independent pathways in which the RAR-independent pathway is characterized by a fenretinide-dependent increase in 12-LOX activity, leading to the induction of GADD153. The targeting of 12-LOX and/or GADD153 in neuroblastoma cells may thus present a novel pathway for the development of drugs inducing apoptosis of neuroblastoma with improved tumor specificity.",
author = "Lovat, {Penny E.} and Serafina Oliverio and Marco Ranalli and Marco Corazzari and Carlo Rodolfo and Francesca Bernassola and Karen Aughton and Mauro Maccarrone and Hewson, {Quentin D Campbell} and Pearson, {Andy D J} and Gerry Melino and Mauro Piacentini and Redfern, {Christopher P F}",
year = "2002",
month = "9",
day = "15",
language = "English",
volume = "62",
pages = "5158--5167",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

TY - JOUR

T1 - GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma

AU - Lovat, Penny E.

AU - Oliverio, Serafina

AU - Ranalli, Marco

AU - Corazzari, Marco

AU - Rodolfo, Carlo

AU - Bernassola, Francesca

AU - Aughton, Karen

AU - Maccarrone, Mauro

AU - Hewson, Quentin D Campbell

AU - Pearson, Andy D J

AU - Melino, Gerry

AU - Piacentini, Mauro

AU - Redfern, Christopher P F

PY - 2002/9/15

Y1 - 2002/9/15

N2 - The synthetic retinoid fenretinide induces apoptosis of neuroblastoma cells and in vitro acts synergistically with chemotherapeutic drugs used to treat neuroblastoma. The mechanisms of fenretinide-induced cell death of neuroblastoma cells are complex, involving cellular signaling pathways as yet incompletely defined but, in part, involving the generation of reactive oxygen species (ROS). In an attempt to characterize the mechanism of action of fenretinide, cDNA array filters were screened to identify apoptotic genes regulated in response to treatment of SH-SY5Y cells with fenretinide. Expression of the stress-induced transcription factor, GADD153, was up-regulated at both the protein and mRNA levels in response to fenretinide. Overexpression of GADD153 increased apoptosis in the presence and absence of fenretinide, whereas reduced expression of GADD153 by expression of antisense DNA abrogated the response to fenretinide. Although fenretinide is a partial retinoic acid receptor (RAR)-β/γ agonist, RARβ/γ antagonists did not block the induction of GADD153 by fenretinide; conversely, the induction of GADD153 was blocked by antioxidants. Enzyme inhibitors were used to identify pathways mediating the ROS-dependent effects of fenretinide: inhibitors of phospholipase A2 and lypoxygenases (LOX), and specific inhibitors of 12-LOX, but not 5-LOX or 15-LOX, inhibited the induction of ROS, apoptosis, and GADD153 in response to fenretinide. The inhibition of ROS and apoptosis was reversed by the addition of the 12-LOX products, 12 (S)-hydroperoxyeicosatetraenoic acid (12-HpETE) and 12 (S)-hydroxyeicosatetraenoic acid (12-HETE). Fenretinide did not increase free arachidonic acid levels, but increased LOX activity without a detectable increase in 12-LOX protein. These results suggest that fenretinide induces apoptosis via RAR-dependent and -independent pathways in which the RAR-independent pathway is characterized by a fenretinide-dependent increase in 12-LOX activity, leading to the induction of GADD153. The targeting of 12-LOX and/or GADD153 in neuroblastoma cells may thus present a novel pathway for the development of drugs inducing apoptosis of neuroblastoma with improved tumor specificity.

AB - The synthetic retinoid fenretinide induces apoptosis of neuroblastoma cells and in vitro acts synergistically with chemotherapeutic drugs used to treat neuroblastoma. The mechanisms of fenretinide-induced cell death of neuroblastoma cells are complex, involving cellular signaling pathways as yet incompletely defined but, in part, involving the generation of reactive oxygen species (ROS). In an attempt to characterize the mechanism of action of fenretinide, cDNA array filters were screened to identify apoptotic genes regulated in response to treatment of SH-SY5Y cells with fenretinide. Expression of the stress-induced transcription factor, GADD153, was up-regulated at both the protein and mRNA levels in response to fenretinide. Overexpression of GADD153 increased apoptosis in the presence and absence of fenretinide, whereas reduced expression of GADD153 by expression of antisense DNA abrogated the response to fenretinide. Although fenretinide is a partial retinoic acid receptor (RAR)-β/γ agonist, RARβ/γ antagonists did not block the induction of GADD153 by fenretinide; conversely, the induction of GADD153 was blocked by antioxidants. Enzyme inhibitors were used to identify pathways mediating the ROS-dependent effects of fenretinide: inhibitors of phospholipase A2 and lypoxygenases (LOX), and specific inhibitors of 12-LOX, but not 5-LOX or 15-LOX, inhibited the induction of ROS, apoptosis, and GADD153 in response to fenretinide. The inhibition of ROS and apoptosis was reversed by the addition of the 12-LOX products, 12 (S)-hydroperoxyeicosatetraenoic acid (12-HpETE) and 12 (S)-hydroxyeicosatetraenoic acid (12-HETE). Fenretinide did not increase free arachidonic acid levels, but increased LOX activity without a detectable increase in 12-LOX protein. These results suggest that fenretinide induces apoptosis via RAR-dependent and -independent pathways in which the RAR-independent pathway is characterized by a fenretinide-dependent increase in 12-LOX activity, leading to the induction of GADD153. The targeting of 12-LOX and/or GADD153 in neuroblastoma cells may thus present a novel pathway for the development of drugs inducing apoptosis of neuroblastoma with improved tumor specificity.

UR - http://www.scopus.com/inward/record.url?scp=0037105654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037105654&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 5158

EP - 5167

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 18

ER -